AVITAC

Serial Number 97813070
732

Registration Progress

Application Filed
Feb 27, 2023
Under Examination
Aug 6, 2024
Approved for Publication
Jun 11, 2024
Published for Opposition
Jun 11, 2024
Registered

Attorney Assistance

Statement of Use Due - Extension 3 Granted
Due: Aug 06, 2027 550 days

Trademark Image

AVITAC

Basic Information

Serial Number
97813070
Filing Date
February 27, 2023
Published for Opposition
June 11, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
732
Status Date
Jan 28, 2026
Application
Pending
Classes
042

Rights Holder

Avilar Therapeutics, Inc.

03
Address
400 Totten Pond Road, Suite 110
Waltham, MA 02451

Ownership History

Avilar Therapeutics, Inc.

Original Applicant
03
Waltham, MA

Avilar Therapeutics, Inc.

Owner at Publication
03
Waltham, MA

Legal Representation

Attorney
Brent R. Bellows

USPTO Deadlines

Next Deadline
550 days remaining
Statement of Use Due - Extension 3 Granted
Due Date
August 06, 2027
Extension Available
Until August 06, 2026

Application History

28 events
Date Code Type Description Documents
Jan 29, 2026 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 28, 2026 EX3G S SOU EXTENSION 3 GRANTED Loading...
Jan 28, 2026 EXT3 S SOU EXTENSION 3 FILED Loading...
Jan 28, 2026 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 5, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 4, 2025 EX2G S SOU EXTENSION 2 GRANTED Loading...
Aug 4, 2025 EXT2 S SOU EXTENSION 2 FILED Loading...
Aug 4, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 3, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 6, 2024 EX1G S SOU EXTENSION 1 GRANTED Loading...
Dec 5, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
Dec 5, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 6, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jun 11, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jun 11, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 22, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 7, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 6, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
May 6, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
May 6, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Feb 26, 2024 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
Feb 26, 2024 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
Nov 29, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Nov 29, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
Nov 29, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Nov 28, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 16, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 2, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Research and development in the field of pharmaceutical preparations that bind to asialoglycoprotein receptors; Research and development in the field of pharmaceuticals targeting diseases mediated by extracellular proteins; Pharmaceutical research and development

Additional Information

Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
042